Skip to content

Immunovant, Inc. IMVT Segment Reporting Other Item Amount

Segment Reporting Other Item Amount at other companies

Essential Utilities logo
Essential UtilitiesWTRG
-$75K+74.4%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-$53K+35.4%
Corvex
 logo
Corvex MOVE
$1.42M
ConocoPhillips logo
ConocoPhillipsCOP
$7.22B+6.1%
SiTime Corporation logo
SiTime CorporationSITM
$71.86M+26.2%
Atmos Energy logo
Atmos EnergyATO
$1.01B-7.3%

Segments

By segment

See full
Reportable Segment-$3.64M

Other financials

Income statement

See full
Net income-$147.9M-38.9%
EPS (diluted)-$0.73-15.9%

Balance sheet

See full
Cash & equivalents$902.1M+26.4%
Total debt$72.0K-26.5%
Total equity$852.6M+20.5%
Total assets$957.0M+23.3%

Cash flow

See full
Operating cash flow-$95.1M+14.1%
CapEx$8.0K-96.0%
Free cash flow-$95.1M+14.2%

Valuation

See full
Market cap$7.26B+74.2%
Enterprise value$6.35B+89.7%

Returns & leverage

See full
Return on equity-64.8%+2.5pp
Debt / equity0.0×
Current ratio9.1×-2.1×